Ideas to action: independent research for global prosperity
Search
Filters:
Experts
Facet Toggle
Topics
Facet Toggle
Publication Type
Facet Toggle
Time Frame
Facet Toggle
CGD NOTES
November 14, 2023
In the wake of a challenging year, the Bank of England (BoE) has found itself navigating a tumultuous economic landscape marked by significant upheavals. Following the release of the mini-budget in September 2022, the BoE was compelled to take proactive measures to stabilize the financial system. Th...
CGD NOTES
June 07, 2023
PM-JAY, India’s national health insurance program, is the largest publicly funded health insurance program in the world. It has reformed the way in which the poor and vulnerable access hospital care in India. The size of this program and the inclusion of private providers in delivering care has led ...
CGD NOTES
December 14, 2022
Almost a year after two oral antiviral treatments received emergency use authorization, demand is extremely low. In this note, we argue that governments and their donor partners should use data and evidence to consider the economic and clinical rationale for registering, financing, purchasing, and d...
CGD NOTES
August 31, 2022
When the G20 pledges of $100 billion of SDR recycling materialize, there will no doubt be much self-congratulatory celebration. But the celebrations will be meaningless if the SDRs do not make their way to the low- and middle-income countries (LMICs) that need them. Will we be able to tell if the SD...
CGD NOTES
May 11, 2022
This note takes a quick look at the lessons learned and the existing landscape of MCM manufacturing in the context of the current pandemic response and suggests eight areas for action along with near-term recommendations to the global community to both prepare and respond to future pandemic risks.
CGD NOTES
April 07, 2022
While oral antivirals are not a substitute for vaccination, they are key to preventing severe illness, saving lives, and preserving health systems. Vaccination rates continue to be low in low-income countries; only 14 percent of the population in low-income countries has received one dose of the vac...
CGD NOTES
March 03, 2022
The COVID-19 pandemic has transformed the global vaccine manufacturing landscape, with capacity more than doubling in the past 18 months. Before the pandemic, manufacturers produced an estimated total of five billion vaccine doses each year. In 2021, manufacturers produced 12 billion doses of C...
CGD NOTES
November 01, 2021
After more than a year of grappling with the economic effects of the COVID-19 pandemic, many middle-income countries (MICs) will continue to experience health and economic dislocation for some time to come. While much of the global financial community’s attention has focused on supporting low-income...
CGD NOTES
September 23, 2021
The August 23 allocation of SDRs has given low- and middle-income countries (LMICs) breathing space on their balance sheets to confront the monetary and fiscal challenges of the economic crisis induced by the COVID-19 pandemic. In the next few weeks, at the UN General Assembly meetings and the annua...